Published in Neurosci Biobehav Rev on November 28, 2007
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med (2012) 1.37
Psychometric evaluation of a radio electric auricular treatment for stress related disorders: a double-blinded, placebo-controlled controlled pilot study. Health Qual Life Outcomes (2010) 1.27
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord (2010) 1.21
Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci (2011) 1.07
Immune system dysregulation in adolescent major depressive disorder. J Affect Disord (2008) 1.04
Medical and substance use comorbidity in bipolar disorder. J Affect Disord (2008) 1.00
Stage managing bipolar disorder. Bipolar Disord (2013) 0.95
Integrated neurobiology of bipolar disorder. Front Psychiatry (2014) 0.93
Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can J Psychiatry (2014) 0.90
Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol (2011) 0.90
Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Mol Psychiatry (2014) 0.89
The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig (2010) 0.89
HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations. Brain Behav (2013) 0.89
Functional outcome in bipolar disorder: the big picture. Depress Res Treat (2011) 0.89
Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Psychopharmacology (Berl) (2014) 0.87
The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder. Compr Psychiatry (2008) 0.86
Staging Models in Bipolar Disorder: A Systematic Review of the Literature. Clin Psychopharmacol Neurosci (2016) 0.85
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. Eur Neuropsychopharmacol (2011) 0.84
The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res (2014) 0.83
Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention. Front Psychiatry (2014) 0.82
Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder. Int J Bipolar Disord (2014) 0.81
A Long Time Coming - The Creation of an Evidence Base for Physical Activity Prescription to Improve Health Outcomes in Bipolar Disorder. Ment Health Phys Act (2010) 0.80
Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load. Psychoneuroendocrinology (2015) 0.80
The influence of psychoeducation on regulating biological rhythm in a sample of patients with bipolar II disorder: a randomized clinical trial. Psychol Res Behav Manag (2014) 0.79
Intersection of Stress, Social Disadvantage, and Life Course Processes: Reframing Trauma and Mental Health. Am J Psychiatr Rehabil (2013) 0.79
Neural processing of emotional facial and semantic expressions in euthymic bipolar disorder (BD) and its association with theory of mind (ToM). PLoS One (2012) 0.79
Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia. Depress Res Treat (2012) 0.79
Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. J Affect Disord (2016) 0.78
Changes in the corpus callosum in women with late-stage bipolar disorder. Acta Psychiatr Scand (2015) 0.78
The Neurobiology of Bipolar Disorder: An Integrated Approach. Chonnam Med J (2016) 0.78
Correlates of treatment response in depressed older adults with bipolar disorder. J Geriatr Psychiatry Neurol (2012) 0.78
The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder. J Psychiatr Res (2011) 0.78
Allostasis as a conceptual framework linking bipolar disorder and addiction. Front Psychiatry (2014) 0.78
Heading off depressive illness evolution and progression to treatment resistance. Dialogues Clin Neurosci (2015) 0.77
Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders. J Affect Disord (2014) 0.77
The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia. BMC Psychiatry (2010) 0.77
The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders. Int J Neuropsychopharmacol (2016) 0.76
Non-invasive vascular imaging is associated with cardiovascular risk factors among adolescents with bipolar disorder. Pediatr Cardiol (2014) 0.76
Promising avenues of therapeutics for bipolar illness. Dialogues Clin Neurosci (2008) 0.76
Bipolar disorder after stroke in an elderly patient. Case Rep Psychiatry (2014) 0.76
Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder. Sci Rep (2016) 0.75
Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity. Int J Neuropsychopharmacol (2016) 0.75
A method for selecting structure-switching aptamers applied to a colorimetric gold nanoparticle assay. J Vis Exp (2015) 0.75
Effect of alcohol and illicit substance use on verbal memory among individuals with bipolar disorder. Psychiatry Res (2016) 0.75
Coping strategies used by poorly adherent patients for self-managing bipolar disorder. Patient Prefer Adherence (2016) 0.75
Fornix Structural Connectivity and Allostatic Load: Empirical Evidence from Schizophrenia Patients and Healthy Controls. Psychosom Med (2017) 0.75
Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry (2017) 0.75
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 3.14
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry (2004) 2.89
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry (2003) 2.66
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord (2005) 2.58
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry (2005) 2.52
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry (2009) 2.50
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry (2007) 2.45
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry (2006) 2.29
The poor prognosis of childhood-onset bipolar disorder. J Pediatr (2007) 2.26
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry (2002) 2.26
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry (2008) 2.17
Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry (2015) 2.15
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry (2011) 2.10
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases. Health Qual Life Outcomes (2010) 1.94
Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry (2002) 1.93
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol (2009) 1.74
Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry (2002) 1.71
Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry (2003) 1.68
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol (2008) 1.60
Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord (2007) 1.59
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry (2009) 1.55
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52
International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry (2004) 1.50
Psychoeducation in bipolar patients with comorbid personality disorders. Bipolar Disord (2004) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry (2002) 1.48
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord (2007) 1.46
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
Neuropsychological disturbances and cerebral blood flow in bipolar disorder. Aust N Z J Psychiatry (2005) 1.46
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry (2005) 1.44
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry (2003) 1.44
New designs for studies of the prophylaxis of bipolar disorder. J Clin Psychopharmacol (2002) 1.39
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord (2008) 1.37
Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother Psychosom (2006) 1.36
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett (2007) 1.35
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett (2006) 1.34
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry (2006) 1.31
Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol (2011) 1.31
No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol (2011) 1.30
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28
Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry (2012) 1.28
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry (2004) 1.27
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull (2007) 1.24
Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry (2006) 1.24
Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev (2008) 1.23
ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol (2008) 1.21
Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol (2008) 1.20
Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry (2007) 1.19
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry (2002) 1.18
Cognitive impairment in bipolar II disorder. Br J Psychiatry (2006) 1.18
Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry (2008) 1.17
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry (2005) 1.17
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry (2005) 1.16
Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom (2014) 1.15
New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord (2010) 1.15
Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord (2008) 1.15
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13
Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disord (2008) 1.13
Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry (2004) 1.13
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry (2006) 1.13
Bipolar depression: overview and commentary. Harv Rev Psychiatry (2010) 1.12
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord (2008) 1.11
Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord (2011) 1.11
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry (2008) 1.10
Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children. J Affect Disord (2003) 1.09
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol Psychiatry (2005) 1.09
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology (2009) 1.09
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08
Differential effectiveness of right unilateral versus bilateral electroconvulsive therapy in resistant bipolar depression. Am J Psychiatry (2015) 1.07
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry (2003) 1.07
Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry (2003) 1.07
Functional impairment and disability across mood states in bipolar disorder. Value Health (2010) 1.06
Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord (2009) 1.06
Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry (2009) 1.05
Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry (2003) 1.05
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry (2002) 1.04
A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol (2006) 1.04